Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
about
Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeuticsVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmStructure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.Real-time detection of implant-associated neutrophil responses using a formyl peptide receptor-targeting NIR nanoprobe.Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Effect of ligand density, receptor density, and nanoparticle size on cell targetingDirect measurement of glyconanoparticles and lectin interactions by isothermal titration calorimetryReduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammationOptimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationApplications of nanomaterials as vaccine adjuvants.Multifunctional nanorods serving as nanobridges to modulate T cell-mediated immunityTargeting strategies for multifunctional nanoparticles in cancer imaging and therapy.Understanding the particokinetics of engineered nanomaterials for safe and effective therapeutic applications.Surface modification of nonviral nanocarriers for enhanced gene delivery.Nanocarriers for vascular delivery of anti-inflammatory agentsTargeted endothelial nanomedicine for common acute pathological conditions.Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation.Targeted Nanotherapies for the Treatment of Surgical Diseases.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Development and screening of a series of antibody-conjugated and silica-coated iron oxide nanoparticles for targeting the prostate-specific membrane antigen.Dispersity effects in polymer self-assemblies: a matter of hierarchical control.Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells.Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma.The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy.Particle Targeting in Complex Biological Media.Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types.Precision engineering of targeted nanocarriers.Evaluation of Receptor-Ligand Mechanisms of Dual-Targeted Particles to an Inflamed Endothelium.Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy.
P2860
Q26823789-BFDFD320-5C10-4708-8161-3CF540278BE6Q27026630-57D9D4BD-EA3B-4774-A940-1E9038571E12Q35318199-2568138D-B1DF-46E7-95AC-8D164BDF435BQ35972636-459DF51B-C34C-45C1-9756-72B7260EDCF3Q36392586-4FE41477-B471-48EA-A4D4-D8B2995BD11CQ36395999-210A15A3-A643-4C43-8538-08FD5C70A984Q36413263-92545C77-C0A1-450E-9DFD-9082C813EA25Q36478846-3284152F-BC43-44F9-BB4E-1BA86393CC49Q36721811-EEA0A70A-03D5-482B-B404-098DBFA3B2C8Q36869824-39ED41A7-73B4-4D16-B00D-05036AA309EFQ36934007-26FD15C5-8C6F-41F6-9FF2-7A8F7D372373Q37159697-76F0F9CD-5E6C-462B-8495-21664BDB1044Q37679496-06FAB055-6664-4096-BB3D-2156204E79FFQ37978315-382684EA-A011-40D9-B26C-BD91AC05A541Q38066154-6D5ED84D-FF7D-434D-AF42-BB3EACAEF449Q38172635-1FDD7AB0-7378-4D4E-A5CA-5508ECE7F95BQ38176037-6637DEC0-4385-4C24-AFB9-3189FE1BC129Q38598987-38FDE976-CAE2-45B9-9932-0B5F3E8658FBQ38691793-9F391E10-E91D-4434-B780-E3B8B862D87EQ38693341-D305D863-4C96-4B95-80B0-DC9A0A873A14Q38899902-B16B1282-608A-4D4D-B7B0-B12BA1263062Q39018873-C6B227D6-9762-497E-A52F-8356BE63C5CAQ39362096-19BCD747-4EFA-4877-92EB-BE55E5AC41BBQ39562431-B644071A-152C-4250-9818-A887DDBBB8B7Q42579276-295DB56A-2950-49DE-B4F6-A12636E43509Q43564347-ED19CA05-AA0A-4F3A-BC5F-D8A8A0DFA0AEQ47794249-283D914E-FB7F-4527-B714-5CBA3D1BDEB1Q49472868-556F4212-540E-45DD-ACEF-31AF9F4612E2Q50049633-98C7B22C-C76A-4DBE-A55E-E854C46387D2Q51055092-ADC78E7C-72F2-41AA-8BE8-0511822C8987Q52608753-D8491EA5-22F5-418D-BBBF-51CBF95EE16D
P2860
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
@en
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
@nl
type
label
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
@en
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
@nl
prefLabel
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
@en
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
@nl
P2093
P2860
P356
P1476
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
@en
P2093
Abdulgader Baoum
Amir Fakhari
Cory Berkland
Khoi Ba Le
Teruna J Siahaan
P2860
P304
P356
10.1002/JPS.22342
P407
P577
2010-10-04T00:00:00Z